Shortage Avoided

PAPAVERINE HYDROCHLORIDE INJECTION USP

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PAPAVERINE HYDROCHLORIDE INJECTION USP in Canada?

Not currently. The most recent shortage report for PAPAVERINE HYDROCHLORIDE INJECTION USP 65MG is marked resolved (last updated August 15, 2024).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength65MG

Last updated2024-08-15

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

00009881

Strength

65MG

Dosage Form

LIQUID

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR

Active Ingredient

PAPAVERINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2024-08-15

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929